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Summary
High-output cardiac failure is rare in newborns. Emergent diagnosis and management of this pathology is crucial. We report the case of a
child, currently 12-months old; obstetric background is non-contributory. Clinic observation on D1 was normal except for the presence of a
systolic cardiac murmur; cardiological evaluation revealed mild ventricular dysfunction of the right ventricle. On the third day of life, she
developed cardiac failure with gallop rhythm, hepatomegaly and a murmur in the anterior fontanel; an echocardiogram confirmed clinic
aggravation with biventricular dysfunction and right cavities and superior vena cava dilatation. The cranial MRI confirmed the presence of a
pial arteriovenous malformation (AVM) involving the anterior and middle cerebral arteries with an associated fronto-parietal ischaemic
lesion. The infant underwent embolisations of AVM with successful flow reduction and cardiac failure improvement. The multidisciplinary
follow-up showed no cardiac dysfunction or permanent lesions but confirmed a severe psycho-motor delay and left hemiparesia.
BACKGROUND
Systemic disorders are the most common manifestations
of intracranial arteriovenous diseases in neonatal age and
cardiac failure is frequently encountered.1 In this group
the most common is vein of Galen malformation (VGM).
However, non-galenic cerebral arteriovenous malforma-
tions (AVMs) or pial AMVs (PAVMs), although rare in
newborns, present much like VGM, also causing congest-
ive cardiac failure in the newborn.1 2
The aetiology remains unknown; their presence in new-
borns suggests that it is a developmental condition.3
However, it is unclear whether PAVMs form early or late
in prenatal development.
Emergent diagnosis and management is crucial as mor-
tality is high during the neonatal period if no treatment is
offered. Generally medical treatment is inefficient, requir-
ing therapeutic embolisation.4
Antenatal diagnosis has been associated with improved
outcome; however, some of these lesions can remain
undetected in prenatal ultrasound.5
We report a case of PAVM resulting in neonatal cardiac
failure, requiring embolisation, which was not detected in
second and third trimester obstetric ultrasound.
CASE PRESENTATION
A 39-week, 2735 g girl was born via caesarean delivery
due to breech presentation, to a healthy 36-year-old
woman. It was an uneventful pregnancy, with normal
TORCH serology, and the prenatal screening ultrasounds
performed at 14, 23 and 36 weeks gestational age were
described as normal, including the central nervous system.
Amniocentesis was performed at 16 weeks gestational
age due to maternal age and the karyotype was normal
(46, XX).
Apgar score was 9 and 10 at minute 1 and 5, respect-
ively, and she was admitted in co-rooming with her
mother.
She was evaluated on D1, without feeding intolerance
and a normal physical exam except for a systolic cardiac
murmur II/VI. A cardiological evaluation was performed
describing a mild ventricular dysfunction especially in the
right ventricle and she was admitted to the neonatal
intensive care unit for surveillance.
On her third day of life she developed feeding intoler-
ance, tachypnoea and intercostals and supraclavicular
retractions, grunting; systolic cardiac murmur III/VI and a
continuous murmur in the anterior fontanel; she
remained afebrile. Analytical tests were normal except for
respiratory acidosis (pH 7.13, PCO2 45.5, HCO3 15.8, BE
−8.8, lactate 7). Chest radiography revealed an enlarged
toraco-cardiac index (figure 1) and echocardiogram
demonstrated enlarged right cavities and a superior vena
Figure 1 Thoracic radiography with cardiomegaly.
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cava with moderate ventricular dysfunction. On day 4,
she was entubated and ventilated.
INVESTIGATIONS
After clinical stabilisation on life day 7 she performed an
MCR-CE which confirmed the presence of a right fronto-
parietal PAVM involving the anterior and middle cerebral
arteries and dilatation of the dural venous sinuses, includ-
ing vein of Galen, secondary to the AVM. A right ischae-
mic lesion was also described near the AVM (figure 2).
TREATMENT
She was transferred to a specialised centre and on day 17
of life an angiography with endovascular embolisation
was made. A PAVM with multiple high-flow arteriovenous
fistulas was found. Embolisation was performed using
detachable coils and N-butyl cyanoacrylated coil and
butylcyanoacrylate glue resulted in partial occlusion of
the fistula.
On life day 25, she was submitted to a second embol-
isation, which was unsuccessful, and 5 days later she was
diagnosed with a late-onset sepsis by Staphylococcus
hominis; she was transferred back to our hospital and
vancomycin and ceftriaxone were initiated, completing
2 weeks of antibiotics.
She maintains clinical signs of mild-to-moderate com-
pensated cardiac failure with systolic cardiac murmur,
gallop rhythm, mild tachypnoea and hepatomegaly (two
fingers below the costal limit), without necessity of venti-
latory support and treated with ionotropics and milrinona.
A third intervention was performed on life day 50 with
embolisation of four more branches of PAVM, resulting in
a marked flow reduction (figure 3). Cardiological evalu-
ation postembolisation revealed a marked improvement
in ventricular function with right cavities with a lesser
degree of dilatation. The patient gradually improved and
inotropic therapy was discontinued.
OUTCOME AND FOLLOW-UP
A development and neurological evaluation was per-
formed: the patient had global axial hypotonia and hyper-
reflexed deep tendon reflex in lower limbs and mild
extrapyramidal signs.
The transfontanelar ultrasound demonstrated extensive
cystic encephalomalacia in the right hemisphere with
frontoparietal white substance atrophy.
She was discharged home at 2 months of age on no
cardiac medications.
At the time of writing, the infant is 12 months of age;
she has moderate psychomotor delay and left hemiparesis.
The latest MRI revealed right hemispheric atrophy and a
residual rim of PAVM.
DISCUSSION
PAVM only represents slightly more than one-quarter of
cerebral AVMs in newborns;1 they correspond to abnormal
communications between arteries and veins directly and
may be located in the posterior fossa or more commonly
in the supratentorial space.2
The intrauterine diagnosis of this vascular anomaly has
been facilitated by prenatal ultrasonography and Doppler
screening. However, as occurred in our case, a PAVM can
remain clinically occult in utero while the fetus is sup-
plied from the placental circulation and after birth as
Figure 2 MRI performed on D7 demonstrated right frontoparietal pial arteriovenous malformation involving the anterior and middle
cerebral arteries and dilatation of dural venous sinuses. A right ischaemic lesion was also described near the AVM.
Figure 3 Embolisation of one of the main feeders with coils and glue.
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the arterial pressure increases and venous resistance
diminishes, the shunt grows in size and flow, producing
haemodynamic decompensation and cardiac failure.3–5
Damage to the brain can occur, depending on the volume
of blood shunted through the malformation and away
from the brain parenchyma causing brain ischaemia (‘steal
phenomenon’).2
Generally shunts that are detected in fetal life are
always associated to cardiac failure at birth and poorer
prognosis.
The main differential diagnosis is the vein of Galen
aneurismal malformations (VGAM) and this differenti-
ation is of paramount importance. In VGAM, manage-
ment can be delayed by 5–6 months whereas in PAVM,
because cerebral tissue injury can develop rapidly, the aim
is to treat as quickly as possible and reduce significantly
shunting through AVM, as soon as possible after delivery
in order to avoid loss of brain substance and to allow neu-
rocognitive development and normal brain maturation.2 3
The chosen treatment is embolisation. Medical manage-
ment can rarely control cardiac failure1 2 6 and endovascu-
lar therapy can provide good outcomes even in patients
with severe cardiac failure and large AVM. Two techniques
are most commonly used: (A) Transarterial embolisation
is more effective in controlling heart failure mainly when
there is only one or a limited number of arteries; this tech-
nique was used on our patient. (B) Transvenous embolisa-
tion is preferred when there are numerous small arterial
feeders and is used by some authors in selected AVM
cases.4 6
The main goal is to obliterate the AVM completely, as
soon as possible. In some cases this is not possible and
partial occlusion is also very beneficial for the improve-
ment of cardiac function.4
The management of neonates with PAVM remains chal-
lenging and implies a multidisciplinary approach to
accomplish the best possible outcome.
Learning points
▸ Systemic disorders are the most common manifestations
of intracranial arteriovenous diseases in neonatal age.
▸ Pial arteriovenous malformation in the newborn
presents as a high-output cardiac failure.
▸ Its identification and rapid treatment are crucial due to
risk of severe and possible irreversible cardiac lesions
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